Showing results (41-50 of 100) with videos related to
Sort By:
Pageof 10
Anticancer Research|September 1, 1993
The spin trap alpha-phenyl-tert-butyl nitrone protects against myelotoxicity and cardiotoxicity of adriamycin while preserving the cytotoxic activityL Paracchini, A Jotti, G Bottiroli, et al.Cancer Research|June 1, 1976
Relationship between activity and amino sugar stereochemistry of daunorubicin and adriamycin derivativesA Di Marco, A M Casazza, R Gambetta, et al.Cancer Research|December 1, 1977
Relationship between effects on nucleic acid synthesis in cell cultures and cytotoxicity of 4-demethoxy derivatives of daunorubicin and adriamycinR Supino, A Necco, T Dasdia, et al.The Histochemical Journal|November 1, 1988
Limitations of the quantitative cytochemical assay of catechol oxidase in melanoma cellsA C Croce, G Bottiroli, E Prosperi, et al.Pharmacology & Therapeutics|April 16, 1998
Role of apoptotic response in cellular resistance to cytotoxic agentsF Zunino, P Perego, S Pilotti, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
Cardiotoxicity and antitumor activity of a copper(II)-doxorubicin chelateE Monti, L Paracchini, F Piccinini, et al.Journal of Cellular Biochemistry|August 31, 2001
Nitroxide TEMPOL impairs mitochondrial function and induces apoptosis in HL60 cellsE Monti, R Supino, M Colleoni, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Comparative studies on the effects of doxorubicin and differentiation inducing agents on B16 melanoma cellsR Supino, M Mariani, A Colombo, et al.Cancer Metastasis Reviews|December 1, 1988
Susceptibility of human and murine drug-resistant tumor cells to the lytic activity of rIL2-activated lymphocytes (LAK)C Gambacorti-Passerini, L Rivoltini, M Radrizzani, et al.British Journal of Cancer|May 1, 1989
P-glycoprotein gene amplification and expression in multidrug-resistant murine P388 and B16 cell linesG Capranico, P De Isabella, C Castelli, et al.Pageof 10